Global mRNA Raw Enzyme Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01246271

Publication Date:

January 4, 2024

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global mRNA Raw Enzyme market size was valued at US$ 3574.8 million in 2023. With growing demand in downstream market, the mRNA Raw Enzyme is forecast to a readjusted size of US$ 1989.8 million by 2030 with a CAGR of -8.0% during review period.
The research report highlights the growth potential of the global mRNA Raw Enzyme market. mRNA Raw Enzyme are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Raw Enzyme. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Raw Enzyme market.
mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials.
In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2'-O-Methyltransferase, Poly(A) Polymerase and DNase I.

The key global manufacturers of mRNA raw enzymes are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, and others. The top two manufacturers together account for 50% of the market share, with the largest manufacturer being Thermo Fisher, accounting for 27% of the market share. The global origin is mainly distributed in North America, Europe, China, Japan, etc. From the consumer level, North America holds the largest market share, accounting for 40%. In terms of its product category, capping enzymes hold the largest market share with 25%, followed by 2'-O-methyltransferase and inorganic pyrophosphatase with 20% and 13%, respectively. In terms of applications, biopharmaceutical companies are the top application area with 80% of the market share, while the rest of the applications are in academic and research institutions.
Key Features:
The report on mRNA Raw Enzyme market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Raw Enzyme market. It may include historical data, market segmentation by Type (e.g., Restriction Enzyme, RNA Polymerase), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Raw Enzyme market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Raw Enzyme market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Raw Enzyme industry. This include advancements in mRNA Raw Enzyme technology, mRNA Raw Enzyme new entrants, mRNA Raw Enzyme new investment, and other innovations that are shaping the future of mRNA Raw Enzyme.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Raw Enzyme market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Raw Enzyme product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Raw Enzyme market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Raw Enzyme market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Raw Enzyme market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Raw Enzyme industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Raw Enzyme market.
Market Segmentation:
mRNA Raw Enzyme market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Restriction Enzyme
RNA Polymerase
Capping Enzyme
Inorganic Pyrophosphatase
RNase Inhibitor
2'-O-Methyltransferase
Poly(A) Polymerase
DNase I
Others
Segmentation by application
Biopharmaceutical Companies
Academic and Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Raw Enzyme Market Size 2019-2030
2.1.2 mRNA Raw Enzyme Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Raw Enzyme Segment by Type
2.2.1 Restriction Enzyme
2.2.2 RNA Polymerase
2.2.3 Capping Enzyme
2.2.4 Inorganic Pyrophosphatase
2.2.5 RNase Inhibitor
2.2.6 2'-O-Methyltransferase
2.2.7 Poly(A) Polymerase
2.2.8 DNase I
2.2.9 Others
2.3 mRNA Raw Enzyme Market Size by Type
2.3.1 mRNA Raw Enzyme Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Raw Enzyme Market Size Market Share by Type (2019-2024)
2.4 mRNA Raw Enzyme Segment by Application
2.4.1 Biopharmaceutical Companies
2.4.2 Academic and Research Institutes
2.5 mRNA Raw Enzyme Market Size by Application
2.5.1 mRNA Raw Enzyme Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Raw Enzyme Market Size Market Share by Application (2019-2024)
3 mRNA Raw Enzyme Market Size by Player
3.1 mRNA Raw Enzyme Market Size Market Share by Players
3.1.1 Global mRNA Raw Enzyme Revenue by Players (2019-2024)
3.1.2 Global mRNA Raw Enzyme Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Raw Enzyme Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Raw Enzyme by Regions
4.1 mRNA Raw Enzyme Market Size by Regions (2019-2024)
4.2 Americas mRNA Raw Enzyme Market Size Growth (2019-2024)
4.3 APAC mRNA Raw Enzyme Market Size Growth (2019-2024)
4.4 Europe mRNA Raw Enzyme Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Raw Enzyme Market Size Growth (2019-2024)
5 Americas
5.1 Americas mRNA Raw Enzyme Market Size by Country (2019-2024)
5.2 Americas mRNA Raw Enzyme Market Size by Type (2019-2024)
5.3 Americas mRNA Raw Enzyme Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Raw Enzyme Market Size by Region (2019-2024)
6.2 APAC mRNA Raw Enzyme Market Size by Type (2019-2024)
6.3 APAC mRNA Raw Enzyme Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Raw Enzyme by Country (2019-2024)
7.2 Europe mRNA Raw Enzyme Market Size by Type (2019-2024)
7.3 Europe mRNA Raw Enzyme Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Raw Enzyme by Region (2019-2024)
8.2 Middle East & Africa mRNA Raw Enzyme Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Raw Enzyme Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Raw Enzyme Market Forecast
10.1 Global mRNA Raw Enzyme Forecast by Regions (2025-2030)
10.1.1 Global mRNA Raw Enzyme Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Raw Enzyme Forecast
10.1.3 APAC mRNA Raw Enzyme Forecast
10.1.4 Europe mRNA Raw Enzyme Forecast
10.1.5 Middle East & Africa mRNA Raw Enzyme Forecast
10.2 Americas mRNA Raw Enzyme Forecast by Country (2025-2030)
10.2.1 United States mRNA Raw Enzyme Market Forecast
10.2.2 Canada mRNA Raw Enzyme Market Forecast
10.2.3 Mexico mRNA Raw Enzyme Market Forecast
10.2.4 Brazil mRNA Raw Enzyme Market Forecast
10.3 APAC mRNA Raw Enzyme Forecast by Region (2025-2030)
10.3.1 China mRNA Raw Enzyme Market Forecast
10.3.2 Japan mRNA Raw Enzyme Market Forecast
10.3.3 Korea mRNA Raw Enzyme Market Forecast
10.3.4 Southeast Asia mRNA Raw Enzyme Market Forecast
10.3.5 India mRNA Raw Enzyme Market Forecast
10.3.6 Australia mRNA Raw Enzyme Market Forecast
10.4 Europe mRNA Raw Enzyme Forecast by Country (2025-2030)
10.4.1 Germany mRNA Raw Enzyme Market Forecast
10.4.2 France mRNA Raw Enzyme Market Forecast
10.4.3 UK mRNA Raw Enzyme Market Forecast
10.4.4 Italy mRNA Raw Enzyme Market Forecast
10.4.5 Russia mRNA Raw Enzyme Market Forecast
10.5 Middle East & Africa mRNA Raw Enzyme Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Raw Enzyme Market Forecast
10.5.2 South Africa mRNA Raw Enzyme Market Forecast
10.5.3 Israel mRNA Raw Enzyme Market Forecast
10.5.4 Turkey mRNA Raw Enzyme Market Forecast
10.5.5 GCC Countries mRNA Raw Enzyme Market Forecast
10.6 Global mRNA Raw Enzyme Forecast by Type (2025-2030)
10.7 Global mRNA Raw Enzyme Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher mRNA Raw Enzyme Product Offered
11.1.3 Thermo Fisher mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 NEB
11.2.1 NEB Company Information
11.2.2 NEB mRNA Raw Enzyme Product Offered
11.2.3 NEB mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 NEB Main Business Overview
11.2.5 NEB Latest Developments
11.3 TriLink Bio Technologies
11.3.1 TriLink Bio Technologies Company Information
11.3.2 TriLink Bio Technologies mRNA Raw Enzyme Product Offered
11.3.3 TriLink Bio Technologies mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 TriLink Bio Technologies Main Business Overview
11.3.5 TriLink Bio Technologies Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck mRNA Raw Enzyme Product Offered
11.4.3 Merck mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Aldevron
11.5.1 Aldevron Company Information
11.5.2 Aldevron mRNA Raw Enzyme Product Offered
11.5.3 Aldevron mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Aldevron Main Business Overview
11.5.5 Aldevron Latest Developments
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Information
11.6.2 Qiagen N.V. mRNA Raw Enzyme Product Offered
11.6.3 Qiagen N.V. mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Qiagen N.V. Main Business Overview
11.6.5 Qiagen N.V. Latest Developments
11.7 Promega
11.7.1 Promega Company Information
11.7.2 Promega mRNA Raw Enzyme Product Offered
11.7.3 Promega mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Promega Main Business Overview
11.7.5 Promega Latest Developments
11.8 Roche CustomBiotech
11.8.1 Roche CustomBiotech Company Information
11.8.2 Roche CustomBiotech mRNA Raw Enzyme Product Offered
11.8.3 Roche CustomBiotech mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Roche CustomBiotech Main Business Overview
11.8.5 Roche CustomBiotech Latest Developments
11.9 Takara Bio Inc.
11.9.1 Takara Bio Inc. Company Information
11.9.2 Takara Bio Inc. mRNA Raw Enzyme Product Offered
11.9.3 Takara Bio Inc. mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Takara Bio Inc. Main Business Overview
11.9.5 Takara Bio Inc. Latest Developments
11.10 Novoprotein
11.10.1 Novoprotein Company Information
11.10.2 Novoprotein mRNA Raw Enzyme Product Offered
11.10.3 Novoprotein mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novoprotein Main Business Overview
11.10.5 Novoprotein Latest Developments
11.11 Vazyme
11.11.1 Vazyme Company Information
11.11.2 Vazyme mRNA Raw Enzyme Product Offered
11.11.3 Vazyme mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vazyme Main Business Overview
11.11.5 Vazyme Latest Developments
11.12 Hongene Biotech Corporatio
11.12.1 Hongene Biotech Corporatio Company Information
11.12.2 Hongene Biotech Corporatio mRNA Raw Enzyme Product Offered
11.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hongene Biotech Corporatio Main Business Overview
11.12.5 Hongene Biotech Corporatio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂